157 related articles for article (PubMed ID: 36362286)
1. Topical Administration of a Novel Acetylated Tetrapeptide Suppresses Vascular Permeability and Immune Responses and Alleviates Atopic Dermatitis in a Murine Model.
Sung B; Baek YY; Kim YM; You JC
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362286
[TBL] [Abstract][Full Text] [Related]
2. Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
Baek YY; Lee DK; Kim J; Kim JH; Park W; Kim T; Han S; Jeoung D; You JC; Lee H; Won MH; Ha KS; Kwon YG; Kim YM
Oncotarget; 2017 Feb; 8(7):11763-11777. PubMed ID: 28052029
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration.
Koo HC; Baek YY; Choi JS; Kim YM; Sung B; Kim MJ; Kim JG; You JC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918777
[TBL] [Abstract][Full Text] [Related]
4. N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases.
Yun JA; Kim J; Baek YY; Park W; Park M; Kim S; Kim T; Choi S; Jeoung D; Lee H; Won MH; Kim JY; Ha KS; Kwon YG; Kim YM
Mol Pharmacol; 2019 Dec; 96(6):692-701. PubMed ID: 31594790
[TBL] [Abstract][Full Text] [Related]
5. Human plasminogen-derived N-acetyl-Arg-Leu-Tyr-Glu antagonizes VEGFR-2 to prevent blood-retinal barrier breakdown in diabetic mice.
Park W; Kim J; Choi S; Kim T; Park M; Kim S; You JC; Kim JH; Ha KS; Lee JH; Kwon YG; Kim YM
Biomed Pharmacother; 2021 Feb; 134():111110. PubMed ID: 33338749
[TBL] [Abstract][Full Text] [Related]
6. Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway.
Park W; Baek YY; Kim J; Jo DH; Choi S; Kim JH; Kim T; Kim S; Park M; Kim JY; Won MH; Ha KS; Kim JH; Kwon YG; Kim YM
Biomol Ther (Seoul); 2019 Sep; 27(5):474-483. PubMed ID: 31042676
[TBL] [Abstract][Full Text] [Related]
7. Bee Venom Phospholipase A2 Ameliorates House Dust Mite Extract Induced Atopic Dermatitis Like Skin Lesions in Mice.
Jung KH; Baek H; Kang M; Kim N; Lee SY; Bae H
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218721
[TBL] [Abstract][Full Text] [Related]
8. A combination of Olea europaea leaf extract and Spirodela polyrhiza extract alleviates atopic dermatitis by modulating immune balance and skin barrier function in a 1-chloro-2,4-dinitrobenzene-induced murine model.
Lee YS; Ryu HW; Yang WK; Park MH; Park YC; Kim DY; Kwon HJ; Kim SY; Oh SR; Kim SH
Phytomedicine; 2021 Feb; 82():153407. PubMed ID: 33571899
[TBL] [Abstract][Full Text] [Related]
9. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
Oh JS; Seong GS; Kim YD; Choung SY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
[TBL] [Abstract][Full Text] [Related]
10. Fermented
Kim SH; Seong GS; Choung SY
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963703
[No Abstract] [Full Text] [Related]
11. Topical application with conjugated linoleic acid ameliorates 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like lesions in BALB/c mice.
Tang L; Cao X; Li X; Ding H
Exp Dermatol; 2021 Feb; 30(2):237-248. PubMed ID: 33206422
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
13.
Oh JS; Lee SJ; Choung SY
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579088
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
15. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Choi YS; Cheong KA; Lee AY
Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
[TBL] [Abstract][Full Text] [Related]
16.
Min GY; Kim JH; Kim TI; Cho WK; Yang JH; Ma JY
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008979
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
18. [Etiopathogenesis of atopic dermatitis].
Kasperska-Zajac A; Koczy-Baron E
Pol Merkur Lekarski; 2011 Nov; 31(185):309-12. PubMed ID: 22299535
[TBL] [Abstract][Full Text] [Related]
19. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
20. Formaldehyde-Induced Aggravation of Pruritus and Dermatitis Is Associated with the Elevated Expression of Th1 Cytokines in a Rat Model of Atopic Dermatitis.
Han RT; Back SK; Lee H; Lee J; Kim HY; Kim HJ; Na HS
PLoS One; 2016; 11(12):e0168466. PubMed ID: 28005965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]